Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.350
-0.100 (-6.90%)
At close: Dec 5, 2025, 4:00 PM EST
1.360
+0.010 (0.74%)
After-hours: Dec 5, 2025, 7:25 PM EST
Neuronetics Employees
Neuronetics had 716 employees as of December 31, 2024. The number of employees increased by 513 or 252.71% compared to the previous year.
Employees
716
Change (1Y)
513
Growth (1Y)
252.71%
Revenue / Employee
$181,387
Profits / Employee
-$62,154
Market Cap
92.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STIM News
- 16 days ago - Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 18 days ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 24 days ago - TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression - GlobeNewsWire
- 4 weeks ago - Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan - GlobeNewsWire
- 5 weeks ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - GlobeNewsWire
- 6 weeks ago - Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call - GlobeNewsWire